Skinvive™ by Juvéderm® – Hyaluronic Acid Skin Quality Treatment

Skinvive™ by Juvéderm® is a non-volumising, microdroplet-based hyaluronic acid injectable designed to improve skin smoothness and hydration.

It offers a distinct alternative to hyaluronic acid skin boosters and differs from dermal fillers by focusing on skin quality rather than structural volume restoration. As part of the Juvéderm® range, it supports natural-looking skin enhancement without altering facial contours.

The treatment is particularly suitable for patients seeking visible improvement in skin appearance without volumetric correction.

Key Benefits

• Hyaluronic acid-based skin quality treatment
• Microdroplet intradermal technique
• Improves skin smoothness and hydration
• No volumising or contouring effect
• Natural-looking results
• Suitable for maintenance and pro-aging protocols

How It Works

Skinvive™ by Juvéderm® works through controlled intradermal delivery of hyaluronic acid using a microdroplet technique.

Hyaluronic acid (cross-linked, low concentration):

• supports hydration within the dermis
• improves skin smoothness and texture
• enhances water retention in the extracellular matrix

Microdroplet distribution:

• ensures even placement within superficial dermal layers
• supports consistent skin quality improvement
• avoids volumetric augmentation

The mechanism is focused on progressive skin quality enhancement rather than structural correction.

Indications

• Dehydrated skin
• Reduced skin smoothness
• Dull skin appearance
• Early signs of ageing
• Patients not requiring volumisation
• Maintenance between aesthetic treatments

Protocol Positioning

Skin Quality vs Structural Treatments

Skinvive™ is positioned differently from dermal fillers, which are designed for volume restoration and structural support.

It can be used as a standalone treatment focused on hydration and smoothness or as part of combination protocols. In particular, it may complement polynucleotide-based treatments in patients requiring both skin quality improvement and regenerative stimulation.

Combination Treatment Strategies

In more advanced protocols, Skinvive™ may be combined with biostimulators to support long-term collagen stimulation and dermal remodelling.

It is often used as:

• an entry-level injectable treatment
• a maintenance solution between volumising procedures
• a complementary step in multi-layer aesthetic protocols

Comparison Within Skin Treatments

Skinvive™ belongs to a category of treatments focused on skin quality improvement, with a distinct clinical positioning

Skinvive™ is specifically designed to improve skin quality without adding volume or altering facial structure.

Product Specification

• Form: injectable gel
• Key component: cross-linked hyaluronic acid
• Technique: microdroplet intradermal injection
• Treatment area: cheeks
• Manufacturer: Allergan Aesthetics (AbbVie)
• Brand: Juvéderm®
• Regulatory status: CE-marked medical device

Related Products & Protocols

For combination treatments and protocol-based approaches, consider:

• Nucleofill – polynucleotide-based regeneration
• Sunekos 200 – amino acid and hyaluronic acid skin rejuvenation

These products may be used alongside Skinvive™ depending on patient needs and treatment goals.

Compliance

This product is a CE-marked medical device intended for use by qualified healthcare professionals.
It should be used in accordance with applicable regulations, IFU and clinical practice guidelines.